← back to search

Georg Jocher

Technical University of Munich · DE
Area of research
Physiology · Neurology
Research interest
Research interests include Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus disease 2019 (COVID-19), ADAM10, Coronavirus, Virology, and Biomarker.
h-index
citations
138
works
2
NIH funding
primary concept
email

Recent publications

ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion
EMBO Reports 2022cited by 126position: firstdoi
Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ‐secretase activity
EMBO Molecular Medicine 2022cited by 12position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Stefan F. Lichtenthaler · Technical University of Munich2 papers (2022–2022)Tuğberk Kaya · University Hospital Bonn1 papers (2022–2022)Laura I. Hofmann · Technical University of Munich1 papers (2022–2022)Carsten B. Schmidt‐Weber · Technical University of Munich1 papers (2022–2022)Tobias Dreyer · German Cancer Research Center1 papers (2022–2022)Axel Imhof · MRC Laboratory of Molecular Biology1 papers (2022–2022)Stanley R. Riddell · Fred Hutch Cancer Center1 papers (2022–2022)Özgün Gökçe · University Hospital Bonn1 papers (2022–2022)Christopher Nimsky · Goethe University Frankfurt1 papers (2022–2022)Kai Zhao · Qingdao University1 papers (2022–2022)M. Sabri Hamad · University of Sharjah1 papers (2022–2022)Madlen Oelsner · Technical University of Munich1 papers (2022–2022)Jakob Trimpert · Institute of Virology of the Slovak Academy of Sciences1 papers (2022–2022)Stephan Breimann · Technical University of Munich1 papers (2022–2022)Gökhan Güner · Technical University of Munich1 papers (2022–2022)Carl Blobel · Hospital for Special Surgery1 papers (2022–2022)Harald Steiner · Ludwig-Maximilians-Universität München1 papers (2022–2022)Holger Bronger · German Cancer Research Center1 papers (2022–2022)Dieter Langosch · Hebrew University of Jerusalem1 papers (2022–2022)Jörg W. Bartsch · Philipps University of Marburg1 papers (2022–2022)